Delivery Order SPE2DB24D3014-SPE2DB25FKTFE
Award Date 4/23/25
Potential Completion Date 4/24/25
Potential Value $1.6K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $1,012.76 to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 40 mg, a prescription stimulant medication commonly used to treat attention deficit hyperactivity disorder and narcolepsy. The contract was competitively awarded with no set-aside designation and carries a firm fixed price structure, with an ultimate completion date of July 8, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the...
- The Defense Logistics Agency awarded a delivery order valued at $2,122.77 to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 30 mg, a prescription stimulant medication commonly used to treat attention deficit hyperactivity disorder. The contract was competitively awarded with no set-aside designation and carries a firm fixed price structure, with an ultimate completion date of August 20, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,963.11 to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 40 mg, a prescription medication commonly used to treat attention deficit hyperactivity disorder. This contract, awarded on June 6, 2025, with an ultimate completion date of June 9, 2025, was issued on a firm fixed-price basis without set-aside restrictions, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a $1,558.70 firm fixed price delivery order to AmerisourceBergen Drug Corp on June 13, 2025, for 100 capsules of Vyvanse 30 mg, a prescription stimulant medication commonly used to treat attention-deficit/hyperactivity disorder. The contract, which is not set-aside and was competitively awarded, has an ultimate completion date of June 16, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a firm fixed-price delivery order valued at $2,048.88 for 100 capsules of Vyvanse 50 mg, a prescription stimulant medication commonly used to treat attention deficit hyperactivity disorder. The contract was competitively awarded without set-aside provisions and carries an ultimate completion date of September 22, 2025. Performance will be executed from the contractor's location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 40 mg, a prescription stimulant medication commonly used to treat attention-deficit/hyperactivity disorder. The contract, valued at $1,192.32 with a firm fixed price structure, was competitively awarded without set-aside designation and is scheduled for completion by August 20, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this delivery...
- The Defense Logistics Agency awarded a $2,239.00 delivery order to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 10 mg, a prescription stimulant medication commonly used to treat attention deficit hyperactivity disorder. The contract was competitively awarded without set-aside designation and is classified as a firm fixed price delivery order, with an ultimate completion date of August 25, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of...
- The Defense Logistics Agency awarded a $2,336.95 delivery order to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 60 mg, a prescription medication commonly used to treat attention-deficit/hyperactivity disorder. The award was made on July 10, 2025, with an ultimate completion date of July 11, 2025, under a firm fixed-price contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, where the pharmaceutical products will be delivered, is a...
- The Defense Logistics Agency awarded a $1,644.49 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 40 mg, a prescription stimulant medication commonly used to treat attention deficit hyperactivity disorder. The contract, awarded on April 23, 2025, with an ultimate completion date of April 24, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). This prime IDC, valued at...
- The Defense Logistics Agency awarded a delivery order valued at $1,407.17 to AmerisourceBergen Drug Corp for Vyvanse 40 mg capsules (100-count units) on August 18, 2025, with an ultimate completion date of August 19, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Vyvanse is a prescription stimulant medication commonly used in military and veteran...